Orthopaedic Department, Rothman Institute at Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107, USA.
J Neurosurg Spine. 2010 Aug;13(2):211-5. doi: 10.3171/2010.3.SPINE09603.
The objective of this study was to examine the efficacy and safety of Healos graft carrier with bone marrow aspirate and local autograft compared with the results of allograft in patients with lumbar degenerative scoliosis undergoing posterolateral fusion.
Twenty-eight patients with degenerative scoliosis underwent posterolateral instrumented fusion and decompression. Patients were grouped according to the graft used. Group A consisted of 12 cases in which the authors used a Healos graft carrier, bone marrow aspirate, and local autograft, and Group B consisted of 16 cases in which the authors used cancellous allograft and local autograft. Patients were followed for a minimum of 2 years postoperatively in terms of pain (visual analog scale), function (Oswestry Disability Index), curve magnitude (Cobb angle), and fusion status (plain and dynamic radiographs). The 2 groups did not differ statistically significantly (p > 0.05) in age, sex, smoking habits, magnitude of preoperative visual analog scale score, Oswestry Disability Index score, Cobb angle, or number of levels requiring decompression and fusion.
The groups had similar (p > 0.05) results in terms of pain, function, curve progression, and fusion rates at the 2-year follow-up examination. Radiographic fusion was achieved in all but 2 cases, 1 in each group, in which the patients were asymptomatic. Patients in the allograft group (Group B) showed evidence of fusion earlier than in the Healos group (p < 0.05). No toxicity from Healos graft was recorded.
The combination of Healos hydroxyapatite sponge and bone marrow aspirate plus local allograft had significantly slower fusion rates but equal clinical outcomes compared with cancellous allograft plus local autograft when used for posterolateral fusion in patients with degenerative lumbar scoliosis.
本研究旨在探讨 Healos 移植物载体联合骨髓抽吸物和自体骨与同种异体骨在接受后路外侧融合术的退变性腰椎侧凸患者中的疗效和安全性。
28 例退变性脊柱侧凸患者接受后路器械固定融合及减压术。根据移植物的使用情况将患者分组。A 组 12 例患者采用 Healos 移植物载体、骨髓抽吸物和自体骨,B 组 16 例患者采用松质骨异体骨和自体骨。所有患者均至少随访 2 年,评估内容包括疼痛(视觉模拟评分)、功能(Oswestry 功能障碍指数)、曲线幅度(Cobb 角)和融合状态(前后位和动力位 X 线片)。两组在年龄、性别、吸烟习惯、术前视觉模拟评分、Oswestry 功能障碍指数评分、Cobb 角、需要减压和融合的节段数量方面差异均无统计学意义(p>0.05)。
两组在疼痛、功能、曲线进展和融合率方面的结果在 2 年随访时相似(p>0.05)。除了每组各有 1 例患者无症状但未融合外,其余患者均融合。异体骨组(B 组)的融合证据比 Healos 组(A 组)更早出现(p<0.05)。未发现 Healos 移植物有任何毒性。
在退变性腰椎侧凸患者中,Healos 羟基磷灰石海绵联合骨髓抽吸物加自体骨与松质骨异体骨加自体骨相比,其融合率明显较慢,但临床结果相当。